TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IDXX

IDEXX Laboratories Inc

Healthcare · Diagnostics & Research

521.50$ +1.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

IDEXX Laboratories Inc (IDXX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,217 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IDXX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
916 902 964 1,004 976 954 998 1,109 1,105 1,091 1,141 1,217 4,553
368 375 371 383 380 384 375 415 422 432 418 437 1,710
548 526 593 621 596 571 623 695 683 658 723 779 2,843
48 52 53 55 54 58 59 62 63 67 66 65 261
89 87 92 157 92 101 92 99 106 109 119 117 450
273 281 294 355 292 309 307 322 329 343 360 354 1,385
275 245 299 264 304 262 317 373 355 316 363 426 1,459
8.6 9.3 7.9 8.1 7.7 7.5 7.7 11 11 11 7.7 10 39
268 240 295 259 299 256 310 362 345 307 355 417 1,424
56 45 60 56 66 40 67 68 70 59 77 79 285
212 195 236 203 233 216 243 294 275 248 278 338 1,140
306 279 335 301 342 299 352 409 392 356 401 468 1,618

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?